Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases

• Váldodahkkit: Michael Hecker (Dahkki), Niklas Frahm (Dahkki), Paula Bachmann (Dahkki), Jane Louisa Debus (Dahkki), Marie-Celine Haker (Dahkki), Pegah Mashhadiakbar (Dahkki), Silvan Elias Langhorst (Dahkki), Julia Baldt (Dahkki), Barbara Streckenbach (Dahkki), Felicita Heidler (Dahkki), Uwe Klaus Zettl (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Patients with multiple sclerosis (MS) often undergo complex treatment regimens, resulting in an increased risk of polypharmacy and potential drug-drug interactions (pDDIs). Drug interaction databases are useful for identifying pDDIs to support safer medication use.Objective: To compare t...